David C. Mis

Array ( [id] => 10649614 [patent_doc_number] => 09365854 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-06-14 [patent_title] => 'LAR protein-specific ligand' [patent_app_type] => utility [patent_app_number] => 13/993870 [patent_app_country] => US [patent_app_date] => 2011-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 12 [patent_no_of_words] => 7301 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9224133 [patent_doc_number] => 20140018908 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-16 [patent_title] => 'Gene Delivery Stent Using Titanium Oxide Thin Film Coating, and Method for Fabricating Same' [patent_app_type] => utility [patent_app_number] => 13/993896 [patent_app_country] => US [patent_app_date] => 2011-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 8291 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13993896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8821059 [patent_doc_number] => 20130122105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-16 [patent_title] => 'Methods and Compositions for Gene Therapy and GHRH Therapy' [patent_app_type] => utility [patent_app_number] => 13/298257 [patent_app_country] => US [patent_app_date] => 2011-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4538 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13298257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10000420 [patent_doc_number] => 09044495 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-02 [patent_title] => 'Nucleic acid ligands to LL37' [patent_app_type] => utility [patent_app_number] => 13/296163 [patent_app_country] => US [patent_app_date] => 2011-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 4811 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13296163 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9620751 [patent_doc_number] => 08790924 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-29 [patent_title] => 'Reversible platelet inhibition' [patent_app_type] => utility [patent_app_number] => 13/296045 [patent_app_country] => US [patent_app_date] => 2011-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 28 [patent_no_of_words] => 15919 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13296045 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9161404 [patent_doc_number] => 20130309681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-21 [patent_title] => 'Immortalization of Epithelial Cells and Methods of Use' [patent_app_type] => utility [patent_app_number] => 13/885078 [patent_app_country] => US [patent_app_date] => 2011-11-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 18400 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13885078 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9120931 [patent_doc_number] => 20130287853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'COMPOSITIONS AND METHODS FOR NANOPOLYMER-BASED NUCLEIC ACID DELIVERY' [patent_app_type] => utility [patent_app_number] => 13/883527 [patent_app_country] => US [patent_app_date] => 2011-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 17959 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13883527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11331055 [patent_doc_number] => 09522288 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-12-20 [patent_title] => 'Upconversion of light for use in optogenetic methods' [patent_app_type] => utility [patent_app_number] => 13/882703 [patent_app_country] => US [patent_app_date] => 2011-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 17051 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13882703 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9227123 [patent_doc_number] => 08632789 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-01-21 [patent_title] => 'System and method for delivery of DNA-binding chemotherapy drugs using nanoparticles' [patent_app_type] => utility [patent_app_number] => 13/286847 [patent_app_country] => US [patent_app_date] => 2011-11-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 4229 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13286847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9191063 [patent_doc_number] => 20130330378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'ANISOTROPIC BIOLOGICAL PACEMAKERS AND AV BYPASSES' [patent_app_type] => utility [patent_app_number] => 13/878383 [patent_app_country] => US [patent_app_date] => 2011-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 14452 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13878383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8094211 [patent_doc_number] => 20120082716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-05 [patent_title] => 'Cytotoxic agents' [patent_app_type] => utility [patent_app_number] => 13/200929 [patent_app_country] => US [patent_app_date] => 2011-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9805 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20120082716.pdf [firstpage_image] =>[orig_patent_app_number] => 13200929 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8055079 [patent_doc_number] => 20120077270 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'Control of Gene Expression Using a Complex of an Oligonucleotide and a Regulatory Peptide' [patent_app_type] => utility [patent_app_number] => 13/251627 [patent_app_country] => US [patent_app_date] => 2011-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 18696 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077270.pdf [firstpage_image] =>[orig_patent_app_number] => 13251627 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8607254 [patent_doc_number] => 20130012566 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-10 [patent_title] => 'Virion Derived Protein Nanoparticles For Delivering Diagnostic Or Therapeutic Agents For The Treatment of Alopecia' [patent_app_type] => utility [patent_app_number] => 13/251742 [patent_app_country] => US [patent_app_date] => 2011-10-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 11934 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13251742 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10498507 [patent_doc_number] => 09226897 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-05 [patent_title] => 'Self-assembling nanoparticles for the release of bisphosphonates in the treatment of human cancers' [patent_app_type] => utility [patent_app_number] => 13/876581 [patent_app_country] => US [patent_app_date] => 2011-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5895 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13876581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7731604 [patent_doc_number] => 20120014976 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-01-19 [patent_title] => 'COMPOSITIONS AND METHODS FOR ENHANCING IMMUNE RESPONSES TO VACCINES' [patent_app_type] => utility [patent_app_number] => 13/243692 [patent_app_country] => US [patent_app_date] => 2011-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 26268 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20120014976.pdf [firstpage_image] =>[orig_patent_app_number] => 13243692 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8891654 [patent_doc_number] => 20130164838 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'METHOD FOR ENRICHMENT OF DNA STRAND BREAK-FREE SPERMATOZOA AND REDUCTION OF RISKS FOR ABNORMALITIES AND/OR ANEUPLOIDY' [patent_app_type] => utility [patent_app_number] => 13/821587 [patent_app_country] => US [patent_app_date] => 2011-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8796 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13821587 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9191511 [patent_doc_number] => 20130330826 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'POLYNUCLEOTIDE DELIVERING COMPLEX FOR TARGET CELL' [patent_app_type] => utility [patent_app_number] => 13/321093 [patent_app_country] => US [patent_app_date] => 2011-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 6449 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13321093 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8381503 [patent_doc_number] => 20120225129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-09-06 [patent_title] => 'CONJUGATES, PARTICLES, COMPOSITIONS, AND RELATED METHODS' [patent_app_type] => utility [patent_app_number] => 13/212951 [patent_app_country] => US [patent_app_date] => 2011-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 88175 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13212951 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8141097 [patent_doc_number] => 20120095075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-04-19 [patent_title] => 'NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS' [patent_app_type] => utility [patent_app_number] => 13/211150 [patent_app_country] => US [patent_app_date] => 2011-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 87154 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20120095075.pdf [firstpage_image] =>[orig_patent_app_number] => 13211150 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9166804 [patent_doc_number] => 08592482 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-11-26 [patent_title] => 'CCR3 inhibition for ocular angiogenesis and macular degeneration' [patent_app_type] => utility [patent_app_number] => 13/177986 [patent_app_country] => US [patent_app_date] => 2011-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 15 [patent_no_of_words] => 6604 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13177986 [rel_patent_id] =>[rel_patent_doc_number] =>)